MedPath

Comparison of TAP block & IL/IH block in Inguinal Hernia Repair patients.

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2021/09/036352
Lead Sponsor
VADDADI RAVITEJ
Brief Summary

This study is a Randomized, double blind, parallel group trail comparing the efficacy of postoperative pain relief between ultrasound guided transversus abdominis plane block and ilioinguinal plane & iliohypogastric nerve block in patients undergoing open inguinal hernia repair under spinal anaesthesia. This trial will be conducted in 60 patients with ASA grades I & II in India. The primary outcome is to measure and compare the duration of postoperative analgesia. Secondarily, to compare the quality of pain relief and requirement of rescue analgesia for the first 48 hours post operatively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • 18 TO 60 Years. ASA Physical status grade.
  • I and II. Patients undergoing elective primary unilateral open inguinal hernia repair.
Exclusion Criteria
  • Patient who refused to consent to study.
  • BMI > 40 kg/m2 Poorly regulated systemic diseases.
  • Local infection at the site of block.
  • Patients with hypersensitivity to local anaesthetic drugs.
  • Patients who will be scheduled for bilateral or recurrent inguinal hernia repair.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
comparision of duration of post operative analgesia48hrs post operatively
Secondary Outcome Measures
NameTimeMethod
compare quality of pain reliefupto 48hrs postoperatively
requirement of rescue analgesiaupto 48hrs postoperatively
incidence of any side effectsupto 48hrs postoperatively

Trial Locations

Locations (1)

IMS AND SUM HOSPITAL

🇮🇳

Khordha, ORISSA, India

IMS AND SUM HOSPITAL
🇮🇳Khordha, ORISSA, India
VADDADI RAVI TEJ
Principal investigator
7799512333
ravitejvaddadi@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.